These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20189816)

  • 1. Design and synthesis of novel series of pyrrole based chemotypes and their evaluation as selective aldose reductase inhibitors. A case of bioisosterism between a carboxylic acid moiety and that of a tetrazole.
    Pegklidou K; Koukoulitsa C; Nicolaou I; Demopoulos VJ
    Bioorg Med Chem; 2010 Mar; 18(6):2107-2114. PubMed ID: 20189816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylation.
    Papastavrou N; Chatzopoulou M; Ballekova J; Cappiello M; Moschini R; Balestri F; Patsilinakos A; Ragno R; Stefek M; Nicolaou I
    Eur J Med Chem; 2017 Apr; 130():328-335. PubMed ID: 28259841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted pyrrol-1-ylacetic acids that combine aldose reductase enzyme inhibitory activity and ability to prevent the nonenzymatic irreversible modification of proteins from monosaccharides.
    Nicolaou I; Demopoulos VJ
    J Med Chem; 2003 Jan; 46(3):417-26. PubMed ID: 12540241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relations on [1-(3,5-difluoro-4-hydroxyphenyl)-1H-pyrrol-3-yl]phenylmethanone. The effect of methoxy substitution on aldose reductase inhibitory activity and selectivity.
    Chatzopoulou M; Mamadou E; Juskova M; Koukoulitsa C; Nicolaou I; Stefek M; Demopoulos VJ
    Bioorg Med Chem; 2011 Feb; 19(4):1426-33. PubMed ID: 21288726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.
    Chen X; Yang Y; Ma B; Zhang S; He M; Gui D; Hussain S; Jing C; Zhu C; Yu Q; Liu Y
    Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing acidity in a series of aldose reductase inhibitors: 2-Fluoro-4-(1H-pyrrol-1-yl)phenol as a scaffold for improved membrane permeation.
    Chatzopoulou M; Patsilinakos A; Vallianatou T; Prnova MS; Zakelj S; Ragno R; Stefek M; Kristl A; Tsantili-Kakoulidou A; Demopoulos VJ
    Bioorg Med Chem; 2014 Apr; 22(7):2194-207. PubMed ID: 24630695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase.
    Chen X; Zhang S; Yang Y; Hussain S; He M; Gui D; Ma B; Jing C; Qiao Z; Zhu C; Yu Q
    Bioorg Med Chem; 2011 Dec; 19(23):7262-9. PubMed ID: 22036211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of N-(3,5-difluoro-4-hydroxyphenyl)benzenesulfonamides as aldose reductase inhibitors.
    Alexiou P; Nicolaou I; Stefek M; Kristl A; Demopoulos VJ
    Bioorg Med Chem; 2008 Apr; 16(7):3926-32. PubMed ID: 18267362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A diverse series of substituted benzenesulfonamides as aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activity.
    Alexiou P; Demopoulos VJ
    J Med Chem; 2010 Nov; 53(21):7756-66. PubMed ID: 20936791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and aldose reductase inhibitory activities of novel O-substituted hydroxyphenylacetic acid derivatives.
    Rakowitz D; Angerer H; Matuszczak B
    Arch Pharm (Weinheim); 2006 Oct; 339(10):547-58. PubMed ID: 17009299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of derivatives of the keto-pyrrolyl-difluorophenol scaffold: some structural aspects for aldose reductase inhibitory activity and selectivity.
    Kotsampasakou E; Demopoulos VJ
    Bioorg Med Chem; 2013 Feb; 21(4):869-73. PubMed ID: 23312612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Hydroxypyrazole as a bioisostere of the acetic acid moiety in a series of aldose reductase inhibitors.
    Papastavrou N; Chatzopoulou M; Pegklidou K; Nicolaou I
    Bioorg Med Chem; 2013 Sep; 21(17):4951-7. PubMed ID: 23891165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase.
    Crespo I; Giménez-Dejoz J; Porté S; Cousido-Siah A; Mitschler A; Podjarny A; Pratsinis H; Kletsas D; Parés X; Ruiz FX; Metwally K; Farrés J
    Eur J Med Chem; 2018 May; 152():160-174. PubMed ID: 29705708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
    Rastelli G; Ferrari AM; Costantino L; Gamberini MC
    Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrrolylbenzothiazole derivatives as aldose reductase inhibitors.
    Zaher N; Nicolaou I; Demopoulos VJ
    J Enzyme Inhib Med Chem; 2002 Apr; 17(2):131-5. PubMed ID: 12420760
    [No Abstract]   [Full Text] [Related]  

  • 16. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
    Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid derivatives of benzisothiazole-1,1-dioxide as inhibitors of rat lens aldose reductase.
    Da Settimo A; Primofiore G; La Motta C; Da Settimo F; Simorini F; Boldrini E; Bianchini P
    Farmaco; 1996 Apr; 51(4):261-7. PubMed ID: 8645413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and aldose reductase inhibitory activity of substituted 2-oxoquinoline-1-acetic acid derivatives.
    DeRuiter J; Brubaker AN; Whitmer WL; Stein JL
    J Med Chem; 1986 Oct; 29(10):2024-8. PubMed ID: 3093680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design synthesis and evaluation of novel aldose reductase inhibitors: The case of indolyl-sulfonyl-phenols.
    Koutsopoulos K; Lavrentaki V; Antoniou I; Kousaxidis A; Lefkopoulou M; Tsantili-Kakoulidou A; Kovacikova L; Stefek M; Nicolaou I
    Bioorg Med Chem; 2020 Aug; 28(15):115575. PubMed ID: 32631572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and aldose reductase inhibitory activities of novel thienocinnolinone derivatives.
    Pau A; Asproni B; Boatto G; Grella GE; De Caprariis P; Costantino L; Pinna GA
    Eur J Pharm Sci; 2004 Mar; 21(4):545-52. PubMed ID: 14998586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.